These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3550644)

  • 21. Peroxynitrite alters the catalytic activity of rodent liver proteasome in vitro and in vivo.
    Osna NA; Haorah J; Krutik VM; Donohue TM
    Hepatology; 2004 Sep; 40(3):574-82. PubMed ID: 15349895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
    Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
    J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antithrombotic effects of molsidomine, isosorbide dinitrate and verapamil in a laser-induced thrombosis model].
    Krupiński K; Breddin H; Bielawiec M
    Kardiol Pol; 1993 Aug; 39(8):100-4. PubMed ID: 8231003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty.
    Groves PH; Banning AP; Penny WJ; Newby AC; Cheadle HA; Lewis MJ
    Cardiovasc Res; 1995 Jul; 30(1):87-96. PubMed ID: 7553728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
    Govantes C; Rodríguez-Martínez MA; Marín J
    Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic effect of L-arginine in hypertensive rats.
    Cylwik D; Mogielnicki A; Kramkowski K; Stokowski J; Buczko W
    J Physiol Pharmacol; 2004 Sep; 55(3):563-74. PubMed ID: 15381827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
    Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Release of plasminogen activator by SIN-1].
    Kloecking HP; Hoffmann A; Markwardt F
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):231-2. PubMed ID: 3104866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: role of contact protein and tissue factor initiation.
    Nielsen VG; Kirklin JK; Holman WL; Steenwyk BL
    ASAIO J; 2009; 55(1):33-40. PubMed ID: 19092656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations on the role of arachidonic acid metabolism pathways in the antithrombotic activity of nafazatrom and molsidomine.
    Massad L; Plotkine M; Boulu RG
    Thromb Res; 1988 Jun; 50(5):617-25. PubMed ID: 3137682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
    Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
    J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of intracoronary injection of SIN-1 on vasoconstriction of epicardial arteries induced by acetylcholine].
    Dubois-Randé JL; Adnot S; Dupouy P; Castaigne A; Geschwind H
    Arch Mal Coeur Vaiss; 1993 Jun; 86(6):881-7. PubMed ID: 8274060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the influence of nitrates, molsidomine and SIN-1, a molsidomine metabolite in acute coronary insufficiency.
    Degré S; Sobolski J; Berkenboom G; Abramowicz M; Vandermoten P; Stoupel E
    Bibl Cardiol; 1985; (39):129-34. PubMed ID: 3842256
    [No Abstract]   [Full Text] [Related]  

  • 35. Alteration of cytosolic free calcium homeostasis by SIN-1: high sensitivity of L-type Ca2+ channels to extracellular oxidative/nitrosative stress in cerebellar granule cells.
    Gutiérrez-Martín Y; Martín-Romero FJ; Henao F; Gutiérrez-Merino C
    J Neurochem; 2005 Feb; 92(4):973-89. PubMed ID: 15686499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of molsidomine and of its active metabolite, SIN-1 (or linsidomine), in the elderly.
    Spreux-Varoquaux O; Ulmer B; Cordonnier P; Forestier A; Pays M; Ducreuzet C; Advenier C
    Fundam Clin Pharmacol; 1991; 5(6):549-56. PubMed ID: 1955198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
    Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
    J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molsidomine: importance in treatment of circulation disorders].
    Kmieć M; Ochmański W
    Przegl Lek; 1998; 55(10):532-6. PubMed ID: 10224868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of SIN-1 and sodium nitroprusside (NANP) on ox-LDL metabolism in macrophages.
    Wybrańska I; Miszczuk-Jamska B; Baczyńska E; Goldsztajn P; Sowa G; Przewłocki R; Gryglewski R; Dembińska-Kieć A
    J Physiol Pharmacol; 1994 Sep; 45(3):387-97. PubMed ID: 7841451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.